You can add items from the left menu by dragging them here.

All therapy regimens used in the investigation seem to be generally well-
tolerated. Even though the final amount of drug-related
adverse events was
significantly greater in the combination group weighed against either
monotherapy group, only 5% or a lesser amount
of men in each treatment group withdrew
from the study caused by these adverse events. The most frequent
(more than
or similar to 2%) adverse events for combination therapy were
erection dysfunction (7. 4%), retrograde ejaculation (4. 2%), altered or/>decreased libido (3. 4%), and ejaculation failure (2. 4%). The most prevalent
adverse events for AVODART as monotherapy were erection
problems (6. 0%)
and altered or decreased libido (2. 8%), as well as for tamsulosin monotherapy was
erection dysfunction (3.
8%). (3)


The International Prostate Symptom Score (IPSS) is often a symptom index
for enlarged prostate that has been developed
and validated using a
multidisciplinary measurement committee in the American Urological
Association (AUA). The ultimate symptom index includes 7 questions
covering
frequency, nocturia, weak urinary (4)stream, hesitancy, intermittence,
incomplete emptying and urgency.


ABOUT AVODART


AVODART, creation only dual 5ARI
for that treatment of enlarged
prostate, inhibits the two type I and type II isoenzymes accountable for
the conversion of
testosterone into dihydrotestosterone (DHT). DHT may be the
primary male hormone responsible for the enlargement of the prostate. AVODART suppresses
DHT by 93 percent at Two years.


AVODART is indicated to the therapy for symptomatic enlarged prostate
that face
men by having an enlarged prostate to increase urinary symptoms, lessen the
likelihood of AUR, reducing the potential risk of
enlarged prostate-related surgery. While some men have fewer problems and symptoms after ninety days of
treatment with AVODART, remedy duration
of at least few months is
usually required to see if AVODART will improve symptoms.


Just a doctor can
identify if symptoms are from an enlarged
prostate but not a far more serious condition including prostate type of cancer.
Men
should see their doctors for regular exams. Females and children must not
take AVODART. buy alesse online without
a prescription Females who are, or could get pregnant must not handle
AVODART as a result of the chance of
a certain birth defect. Men treated
with AVODART should not donate blood until at the least half a year after
their
final dose zyban online no prescription.


Caution ought to be employed in patients with liver disease. Possible
side
effects include sexual uncomfortable side effects and breast tenderness and/or swelling. These unwanted effects occur infrequently. For full prescribing
information,
see http://www. avodart. com.


About Enlarged Prostate


Enlarged prostate is often a prevalent and progressive condition that affects/>50 percent in men 50 years old as well as over 90 % of men older
than age 80. 5
An enlarged prostate causes modifications to urinary habits because
of the company's location about the urethra. Over time, the prostate
can continue to
grow and urinary symptoms may worsen because the bladder loses to be able to
empty itself. Unattended,
in severe cases, an enlarged prostate can
bring about serious long-term problems including acute urinary retention (AUR)
and the need
for prostate-related surgery, plus in rare cases even kidney or
bladder damage. (6)


About GlaxoSmithKline


GlaxoSmithKline -- one of many
world's leading research-based
pharmaceutical and healthcare companies -- is dedicated to increasing the
quality of human life by enabling individuals
do more, feel great and live
longer.


Cautionary statement regarding forward-looking statements


Beneath the safe harbor provisions of america
Private Securities
Litigation Reform Act of 1995, the organization cautions investors that any
forward-looking statements or projections expressed by the
company, including
those produced in this news release, are subject to risks and uncertainties
that may cause actual brings about
differ materially from those projected. Factors that could change the Group's operations are described under 'Risk
Factors' in the 'Operating
and Financial Review and Prospects' inside
company's Annual Report 2006.


References:


(1) McConnell J, Roehrborn C, Bautista O, et
al. The Long-Term Effect of
Doxazosin, Finasteride, and Combination Therapy within the Clinical
Advancement of Benign Prostatic Hyperplasia. N Engl
J Med 2003 Dec;
349(25):2387-2398.


(2) Mayo Clinic Staff. Enlarged Prostate (BPH). http://www. mayoclinic. com/health/enlarged-prostatebph/BP99999/PAGE=BP00009. Accessed on January 7,
2008.


(3) Roehrborn C, Siami P, Barkin J, et al. The Effects of Dutasteride,
Tamsulosin and Combination Therapy on
Lower Urinary system Symptoms in
Men with Benign Prostatic Hyperplasia and Prostatic Enlargement: 2
Year Comes from the CombAT Study.
J Urol 2008 Feb; 179: 616-621.


(4) Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological/>Association symptom index for benign prostatic hyperplasia. J Urol
1992 Nov; 148(5):1549-57. Accessed on January 7, 2008 via
http://www. primeanswers.
org/primeanswers/calculators/bph. cfm


(5) Presti JC Jr. Neoplasms from the prostate-related. In: Tanagho EA,
McAninch JW, eds. Smith's General Urology 15th
ed. New York, NY:
Lange Medical Books/McGraw-Hill Professions Division: 2000:399-421.


(6) National Institute for Diabetes and Digestive and Kidney
Disease
(NIDDK). Prostate Enlargement: Benign Prostatic Hyperplasia.


GlaxoSmithKline

http://www. gsk. com


.